Classifying for HER2 Dependence to De-Escalate Neoadjuvant Chemotherapy in Patients With HER2+ Early Breast Cancer Undergoing HER2 Double-Blockade
Classifying for HER2 Dependence to De-Escalate Neoadjuvant Chemotherapy in Patients With HER2+ Early Breast Cancer Undergoing HER2 Double-Blockade
Active, not recruiting · NCT06068985 · Registry updated 2026-08-28Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Classifying for HER2 Dependence to De-Escalate Neoadjuvant Chemotherapy in Patients With HER2+ Early Breast Cancer Undergoing HER2 Double-Blockade | Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder | Active, not recruiting | Phase 2 | 2026-08-28 | NCT06068985 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Latin American Cooperative Oncology Group | 16 |
| Oncoclínicas | 1 |
| Roche Pharma AG | 59 |
8 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Centro de Pesquisa em Oncologia do Hospital São Lucas da PUCRS - CPO | Porto Alegre | Brazil | 1 |
| Centro Paulista de Oncologia (Oncoclínicas) | São Paulo | Brazil | 1 |
| Hospital da Fundação Oswaldo Aranha - HFOA | Volta Redonda | Brazil | 1 |
| Hospital de Amor de Barretos | São Paulo | Brazil | 1 |
| Instituto Nacional de Câncer - INCA | Rio de Janeiro | Brazil | 1 |
| Núcleo de Oncologia da Bahia - NOB (Oncoclínicas) | Salvador | Brazil | 1 |
| Oncocentro Belo Horizonte (Oncoclínicas) | Belo Horizonte | Brazil | 1 |
| Universidade Estadual de Campinas - UNICAMP | Campinas | Brazil | 1 |